MAPK3 and breast carcinoma: Mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase 1/2 (ERK1/2) along with PI3K/AKT pathways are jointly induced by PRL and EGF through their corresponding receptors, promoting the proliferation, survival, and metastasis of breast cancer cells [26].